COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 136 filers reported holding COGENT BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,268,754 | -17.7% | 5,566,026 | 0.0% | 6.34% | -14.4% |
| Q2 2023 | $65,901,748 | +28.0% | 5,566,026 | +16.6% | 7.41% | -5.5% |
| Q1 2023 | $51,494,423 | +103014.6% | 4,772,421 | +10.5% | 7.84% | +4.2% |
| Q4 2022 | $49,939 | -99.9% | 4,319,940 | 0.0% | 7.53% | -27.4% |
| Q3 2022 | $64,454,000 | +44.5% | 4,319,940 | -12.6% | 10.36% | +9.9% |
| Q2 2022 | $44,601,000 | +70.1% | 4,944,708 | +41.2% | 9.43% | +61.0% |
| Q1 2022 | $26,221,000 | +34.0% | 3,500,768 | +53.5% | 5.86% | +29.2% |
| Q4 2021 | $19,574,000 | +21.7% | 2,281,315 | +19.3% | 4.53% | +6.9% |
| Q3 2021 | $16,084,000 | +45.0% | 1,912,511 | +39.8% | 4.24% | +9.8% |
| Q2 2021 | $11,091,000 | -0.5% | 1,367,582 | +7.8% | 3.86% | -13.0% |
| Q1 2021 | $11,144,000 | +30.6% | 1,269,195 | +67.0% | 4.44% | -4.3% |
| Q4 2020 | $8,535,000 | – | 760,025 | – | 4.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |